FDA Inspection 1064704 — New York Blood Center Enterprises

New York Blood Center Enterprises — FEI 2473015

The FDA completed an inspection of New York Blood Center Enterprises on August 7, 2018 in Rye, NY. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
August 7, 2018
Fiscal Year
2018
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Rye, NY (United States)